2017/2710(DEA)
Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections
Basic information
2017/2710(DEA)
DEA - Delegated acts procedure
Supplementing 2012/0192(COD)
Subject
4.20.04 Pharmaceutical products and industry
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed ENVIEnvironment, Climate and Food Safety
Key events
Date | Event | Reference | Summary |
---|---|---|---|
23/05/2017 | Non-legislative basic document published | C(2017)03368 | |
23/05/2017 | Initial period for examining delegated act 2.0 month(s) | ||
31/05/2017 | Committee referral announced in Parliament | ||
17/07/2017 | Delegated act not objected by Council | ||
01/08/2017 | Delegated act not objected by Parliament |
Technical information
Procedure reference | 2017/2710(DEA) |
---|---|
Procedure type | DEA - Delegated acts procedure |
Procedure subtype | Examination of delegated act |
Supplementing 2012/0192(COD) | |
Stage reached in procedure | Procedure completed - delegated act enters into force |
Committee dossier |
ENVI/8/10003
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2017)03368 23/05/2017 Document attached to the procedure C(2019)6491 06/09/2019